person

Peter V.

Country
Belgium
Department
Department of Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
51
Sites with multiple studies

Has run more than one trial at 51 of 131 partner sites.

Specializations

Lymphoma Research

This investigator specializes in treating various forms of non-Hodgkin lymphoma, with particular emphasis on B-cell lymphomas. Their research encompasses innovative approaches for relapsed/refractory large B-cell lymphoma management.

  • Diffuse Large B-cell Lymphoma (DLBCL)
  • CAR T-cell therapy applications
  • Novel therapeutic regimens

Their work includes evaluating advanced treatment options for patients who are not eligible for conventional therapies.

Leukemia Studies

The investigator focuses on advancing treatments for chronic myeloid leukemia, exploring both established and emerging therapeutic approaches. Their research includes evaluation of novel tyrosine kinase inhibitors and innovative molecular targeted therapies.

  • First-line CML treatments
  • Molecular response assessment
  • Novel therapeutic compounds

Their work encompasses both newly diagnosed cases and treatment-resistant forms of the disease.

Specialized Conditions

The investigator conducts research in rare hematological disorders, including Hypereosinophilic Syndrome (HES). They also participate in long-term follow-up studies of gene-modified cell therapies for various hematological malignancies.

  • Targeted biological therapies
  • Long-term safety monitoring
  • Rare blood disorders

Their research includes monitoring late-onset effects and treatment outcomes in various patient populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.